Table 4.
Cyclophilin inhibitor | Clearance (liter/h/kg) | t1/2 (h) | Vss (liter/kg) | AUClastb (h · ng/ml) |
p.o. Cmaxc (ng/ml) | F (%) | |
---|---|---|---|---|---|---|---|
I.v. | P.o. | ||||||
SfA | 0.054 | 8.02 | 0.522 | 16,473 | 2,332 | 192 | 1.42 |
SfB | 0.068 | 5.89 | 0.439 | 14,067 | 5,693 | 809 | 3.94 |
SfC | 0.824 | 1.11 | 0.383 | 1,257 | 26 | 22 | 0.21 |
SfD | 0.545 | 1.64 | 0.244 | 2,157 | 20 | 12 | 0.09 |
Data were generated after analysis of whole-blood samples, following doses of 1 mg/kg i.v. and 10 mg/kg p.o. to CD1 mice.
AUClast, area under the concentration-time curve.
Cmax, maximum concentration of drug in serum.